Nir Kossovsky is CEO of Technology Option Capital LLC, which provides business solutions at the interface of alternative risk transfer, intangible asset value and finance. Previously, he was founder and CEO of Patent & License Exchange Inc. and a tenured faculty member at the School of Medicine at the University of California, Los Angeles, where he founded the Biomaterials Bioreactivity Characterization Laboratory. Kossovsky also founded Medical Materials & Devices Inc. and served as a technical and forensic consultant to clients in the medical-device and nanomaterial fields. He is also a principal with Heisenberg Principals Inc., a consultancy specializing in intellectual-property risk management. The author of more than 180 technical papers and book chapters, Kossovsky is the named inventor on 20 pending and issued patents in medical therapeutics, nanotechnology and intellectual property business systems; executive secretary of the Intellectual Asset Finance Society; and a captain in the U.S. Navy Reserve. He earned an M.D. at the University of Chicago, an MBA at the University of Southern California and a certificate in national-security decision making, strategy and operations at the Navy War College.
Global Conference 2013
Former Prime Minister Tony Blair, philanthropist Bill Gates and Strive Masiyiwa of Econet Wireless discuss advancing prosperity in Africa.
